Geode Capital Management’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.3K | Hold |
|
|||||
|
2025
Q1 | $88K | Buy |
|
|||||
|
2024
Q4 | $140K | Buy |
|
|||||
|
2024
Q3 | $110K | Buy |
|
|||||
|
2024
Q2 | $145K | Buy |
|
|||||
|
2024
Q1 | $135K | Buy |
|
|||||
|
2023
Q4 | $82.2K | Hold |
|
|||||
|
2023
Q3 | $73.2K | Sell |
|
|||||
|
2023
Q2 | $74.3K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $48K | Sell |
|
|||||
|
2022
Q3 | $97K | Hold |
|
|||||
|
2022
Q2 | $111K | Hold |
|
|||||
|
2022
Q1 | $279K | Hold |
|
|||||
|
2021
Q4 | $430K | Sell |
|
|||||
|
2021
Q3 | $1.01M | Buy |
|
|||||
|
2021
Q2 | $509K | Sell |
|
|||||
|
2021
Q1 | $821K | Buy |
|
|||||
|
2020
Q4 | $726K | Buy |
|
|||||
|
2020
Q3 | $3.21M | Buy |
|
|||||
|
2020
Q2 | $4.12M | Buy |
|
|||||
|
2020
Q1 | $3.34M | Buy |
|
|||||
|
2019
Q4 | $4.01M | Buy |
|